• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Implantable Provider Group Secures a Three-Fold Increase in Their Line of Credit from Silicon Valley Bank

Implantable Provider Group Secures a Three-Fold Increase in Their Line of Credit from Silicon Valley Bank

October 5, 2011 By MassDevice Contributors Network

Implantable Provider Group Secures a Three-Fold Increase in Their Line of Credit from Silicon Valley Bank

ATLANTA–(BUSINESS WIRE)–Implantable Provider Group (IPG), a leader in providing market based medical implant solutions that deliver tangible value to payors, manufacturers, providers and patients, has secured a three-fold increase in their line of credit arrangement with Silicon Valley Bank. Profitable since inception in 2004, IPG has grown at a 76% compounded annual rate for the past seven years, with a primary focus on large, fast-growth device intensive markets, such as cardiology, neurology, orthopedic and spine implants.

Over the last several years, Implantable Provider Group has been privileged to engage in a number of ongoing partnerships with national and regional health plans breaking new ground for them in lowering implantable device costs while delivering more transparency and predictability to their implantable device spend. IPG is solving the problem of price variability, high markups, and utilization and trend increases that have historically plagued health plans’ implantable device management.

“As the implantable device market continues to grow, IPG is committed to providing valuable solutions that address the continued rising costs in healthcare. We are excited to be partnering with Silicon Valley Bank, which will afford the company additional access to working capital to expand our infrastructure in support of our rapidly growing payor base. This will enable us to aggressively deploy key technology to deliver added efficiencies to our customers and drive future growth. SVB has been a strong and creative partner for us in working with both our financing needs and bank technology support,” said Todd Rielly, Chief Financial Officer for IPG.

“Helping life science and technology companies position themselves for growth is what we do best,” said Chris Stanley, relationship manager for Silicon Valley Bank. ”IPG is focused on a critical sector of the market and we’re proud to be able to support its efforts with the financing it needs to achieve its goals.”

About Implantable Provider Group

Implantable Provider Group streamlines the management and delivery of implantable medical devices by working directly with commercial insurance payors, clinical providers and facilities, and medical device manufacturers. IPG eliminates the complexity and financial risks associated with the billing and reimbursement processes for providers, subsequently improving quality, affordability, and patient access to innovative life-saving and life-enhancing device-intensive medical therapies. In 2008, and again in 2011, IPG earned the exclusive ranking of one of the nation’s fastest-growing private companies in America by Inc. Magazine. Additionally, IPG received the Pacesetter award from Atlanta Business Chronicle in 2011. For more information about IPG, call us at 1-866-753-0046, or visit us on the web at www.ipgsurgical.com.

About Silicon Valley Bank

Silicon Valley Bank is the premier bank for technology, life science, cleantech, venture capital, private equity and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment and international banking services to its clients worldwide through 26 U.S. offices and seven international operations. (Nasdaq: SIVB) www.svb.com.

Silicon Valley Bank is the California bank subsidiary and the commercial banking operation of SVB Financial Group. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System. SVB Financial Group is also a member of the Federal Reserve System.

Contacts

For Implantable Provider Group
Cookerly Public Relations
Tracy Paden, 404-227-4580
[email protected]

Filed Under: Uncategorized Tagged With: Press Release, Silicon Valley Bank

More recent news

  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure
  • NanoVibronix enters into $50M financing agreement

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy